ABVC BioPharma, Inc. (ABVC)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | — | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-03) · 99.1 | ||
| 10-Q/A | Q3-2025 | |||
| 10-Q | Q3-2025 | 8-K (2025-11-03) · 99.1 | 8-K (2025-08-14) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-05-01) · 99.1 | ||
| 10-Q | Q1-2025 | — | ||
| 10-K | FY-2024 | 8-K (2025-04-15) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-14) · 99.1 | 8-K (2024-08-15) · 99.1 | ||
| 10-Q | Q2-2024 | — | ||
| 10-Q | Q1-2024 | 8-K (2024-03-14) · 99.1 | ||
| 10-K/A | FY-2023 | |||
| 10-K | FY-2023 | — | ||
| 10-Q | Q3-2023 | 8-K (2023-11-15) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-07-24) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Document and Entity Information | — |
|
| Audit Information | — |
|
| Statements | ||
| Unaudited Condensed Consolidated Balance Sheets | — |
|
| Consolidated Balance Sheets | ||
| Unaudited Condensed Consolidated Balance Sheets (P) | — |
|
| Consolidated Balance Sheets (P) | ||
| Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss | — |
|
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Consolidated Statements of Operations and Comprehensive Loss (P) | ||
| Unaudited Condensed Consolidated Statements of Cash Flows | — |
|
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Stockholders Equity (deficit) | ||
| Unaudited Condensed Consolidated Statements of Stockholders Equity (deficit) | — |
|
| Consolidated Statements of Stockholders Equity | — |
|
| Notes | ||
| Accrued Expenses and Other Current Liabilities | ||
| Acquisition | — |
|
| Bank Loans | ||
| Collaborative Agreements | ||
| Commitments and Contingencies | ||
| Convertible Notes Payable | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Equity | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Lease | ||
| Liquidity and Going Concern | ||
| Liquidity, Going Concern, and Restatement | ||
| Long-term Investments | ||
| Loss Per Share | ||
| Organization and Description of Business | ||
| Pay Vs Performance Disclosure | ||
| Property and Equipment | ||
| Property and Equipment, and Prepament For Asset Acquisition | ||
| Property and Equipment, and Prepayment For Asset Acquisition | ||
| Related Parties Transactions | ||
| Short-term Loans | ||
| Stock Options | ||
| Stock Options and Warrants | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||